{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T20:32:54Z","timestamp":1793046774292,"version":"4.5.0"},"reference-count":20,"publisher":"S.C. JURNALUL PENTRU MEDICINA SI VIATA S.R.L","issue":"4","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JMedLife"],"abstract":"<jats:p>Intrauterine growth restriction (IUGR) is a common reason for perinatal morbidity and mortality. Also, it is often complicated with fetal distress. Melatonin is widely known as an anti-oxidant agent, and it might decrease the damage of tissues caused by hypoxia. It is also known that levels of pro- and anti-inflammatory cytokines are changed during pregnancy. Placental growth factor (PlGF) is responsible for the angiogenesis in the placenta. We aimed to investigate whether the level of melatonin, cytokines, and PlGF in umbilical blood after birth is different in the case of IUGR compared to normal fetuses. Fourteen women whose pregnancies were complicated with IUGR were included in the study group. The presence of IUGR was confirmed by ultrasound fetometry in the third pregnancy trimester, 30-36 weeks of gestation. All patients delivered their children vaginally after 37 weeks of pregnancy. The cases of severe fetal distress that required a caesarian section, obstetrical forceps, or vacuum extraction of the fetus were excluded from the study. We found that the concentrations of cytokines did not differ significantly between the groups. Also, no significant difference in the daytime of delivery was found between the groups. The concentrations of melatonin and PlGF in the umbilical blood at labor were significantly lowered in the case of IUGR compared to normal pregnancies. This fact, as we consider, is caused by altered production of melatonin and PlGF by the placenta. Therefore, the protective action of these two factors for the fetus at labor is decreased in IUGR.<\/jats:p>","DOI":"10.25122\/jml-2020-0128","type":"journal-article","created":{"date-parts":[[2022,11,18]],"date-time":"2022-11-18T08:33:39Z","timestamp":1668760419000},"page":"548-553","source":"Crossref","is-referenced-by-count":19,"title":["Melatonin Levels Decrease in the Umbilical Cord in Case of Intrauterine Growth Restriction"],"prefix":"10.25122","volume":"13","author":[{"given":"Andrii Mykolaiovych","family":"Berbets","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Department of Obstetrics and Gynecology, Bukovinian State Medical University, Chernivtsi, Ukraine","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Andrii Mykolaiovych Berbets, PhD Student 2, Teatralna Sq, Chernivtsi, Ukraine, 58000.Phone: +380501714679 E-mail: andriy.berbets@gmail.com","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian Mykhailovych","family":"Barbe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Department of Obstetrics and Gynecology, Bukovinian State Medical University, Chernivtsi, Ukraine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oksana Anatoliivna","family":"Andriiets","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Department of Obstetrics and Gynecology, Bukovinian State Medical University, Chernivtsi, Ukraine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anatolii Volodymyrovych","family":"Andriiets","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Department of Obstetrics and Gynecology, Bukovinian State Medical University, Chernivtsi, Ukraine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oleksandr Mykhailovych","family":"Yuzko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Department of Obstetrics and Gynecology, Bukovinian State Medical University, Chernivtsi, Ukraine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10755","published-online":{"date-parts":[[2020,10]]},"reference":[{"key":"ref1","unstructured":"1. Grishchenko VI. Rol' epifiza v fiziologii i patologii zhenskoy polovoy sistemy [Role of a pineal gland in physiology and pathology of woman\u2019s reproductive system]. Khar'kov: Vishcha shkola; 1979. 248 s. (in Russian)."},{"key":"ref2","doi-asserted-by":"crossref","unstructured":"2. Shimada M, Seki H, Samejima M, Hayase M, Shirai F. Salivary melatonin levels and sleep-wake rhythms in pregnant women with hypertensive and glucose metabolic disorders: A prospective analysis. BioSci Trends. 2016;10(1):34-41. doi: 10.5582\/bst.2015.01123","DOI":"10.5582\/bst.2015.01123"},{"key":"ref3","doi-asserted-by":"crossref","unstructured":"3. Soliman A, Lacasse A, Lanoix D, Sagrillo-Fagundes L, Boulard V, Vaillancourt C. Placental melatonin system is present throughout pregnancy and regulates villous trophoblast differentiation. J Pineal Res. 2015;59(1):38-46. doi: 10.1111\/jpi.12236","DOI":"10.1111\/jpi.12236"},{"key":"ref4","doi-asserted-by":"crossref","unstructured":"4. Takayama H, Nakamura Y, Tamura H. Pineal gland (melatonin) affects the parturition time but not luteal function and fetal growth, in pregnant rats. Endocr J. 2003;50(1):37-43. doi: 10.1507\/endocrj. 50.37","DOI":"10.1507\/endocrj.50.37"},{"key":"ref5","doi-asserted-by":"crossref","unstructured":"5. Richter HG, Hansell JA, Raut Sh, Giussani DA. Melatonin improves placental efficiency and birth weight and increases the placental expression of antioxidant enzymes in undernourished pregnancy. J Pineal Res. 2009;46:357-364. doi: 10.1111\/j.1600-079X.2009.00671.x","DOI":"10.1111\/j.1600-079X.2009.00671.x"},{"key":"ref6","doi-asserted-by":"crossref","unstructured":"6. Reiter RJ, Dun Xian Tan, Korkmaz A, Rosales-Corral SA. Melatonin and stable circadian rhythms optimize maternal, placental and fetal physiology. Hum Reprod Update. 2013;20(2):293-307. doi: 10.1093\/humupd\/dmt054","DOI":"10.1093\/humupd\/dmt054"},{"key":"ref7","doi-asserted-by":"crossref","unstructured":"7. Marseglia L, D\u2019Angelo G, Manti S, Reiter RJ, Gitto E. Potential Utility of melatonin in preeclampsia, intrauterine fetal growth retardation, and perinatal asphyxia. Reprod Sci. 2016;23(8):970-977. doi: 10.1177\/1933719115612132","DOI":"10.1177\/1933719115612132"},{"key":"ref8","doi-asserted-by":"crossref","unstructured":"8. Berbets A, Koval H, Barbe A, Albota O, Yuzko O. Melatonin decreases and cytokines increase in women with placental insufficiency [published online ahead of print, 2019 Apr 25]. J Matern Fetal Neonatal Med. 2019;1-6. doi:10.1080\/14767058.2019.1608432","DOI":"10.1080\/14767058.2019.1608432"},{"key":"ref9","doi-asserted-by":"crossref","unstructured":"9. Bentona S, McCowan L, Heazell A. et al. Placental growth factor as a marker of fetal growth restriction caused by placental dysfunction. Placenta. 2016 Jun;42:1-8. doi: 10.1016\/j.placenta. 2016.03.010. Epub 2016 Mar 23.","DOI":"10.1016\/j.placenta.2016.03.010"},{"key":"ref10","doi-asserted-by":"crossref","unstructured":"10. Ong C, Liao A, Cacho A et al. First-trimester maternal serum levels of placenta growth factor as predictor preeclampsia and fetal growth restriction, Am. J. Obstet. Gynecol. 98 (4) (2001) 608-611. doi: 10.1016\/s0029-7844(01)01528-9.","DOI":"10.1016\/S0029-7844(01)01528-9"},{"key":"ref11","doi-asserted-by":"crossref","unstructured":"11. Berbets A, Konkov D, Bulavenko O, Taran O, Bakun O. Melatonin, placental growth factor and placental hormones at placental insufficiency. Cell and Organ Transplantology. 2019; 7(2):103-107. doi:10.22494\/cot.v7i2.100","DOI":"10.22494\/cot.v7i2.100"},{"key":"ref12","doi-asserted-by":"crossref","unstructured":"12. Bligh LN, Greer RM, Kumar S. The relationship between maternal placental growth factor levels and intrapartum fetal compromise. Placenta. 2016 Dec;48:63-67. doi: 10.1016\/j.placenta. 2016.10.007.","DOI":"10.1016\/j.placenta.2016.10.007"},{"key":"ref13","doi-asserted-by":"crossref","unstructured":"13. Kwiatkowski S, Kwiatkowska E, Rzepka R, Do\u0142egowska B, Torbe A, Bartosik-S\u0142awi\u0144ska A. Using Doppler ultrasound of the uterine and umbilical arteries and disordered angiogenesis markers (sFlt-1\/PlGF) in unified monitoring of ischemic placental syndrome patients. Hypertens Pregnancy. 2016 Nov;35(4):490-498. Epub 2016 Jun 17. doi: 10.1080\/10641955.2016.1186688.","DOI":"10.1080\/10641955.2016.1186688"},{"key":"ref14","doi-asserted-by":"crossref","unstructured":"14. Broere-Brown ZA, Schalekamp-Timmermans S, Jaddoe VWV, Steegers EAP. Fetal Growth and Placental Growth Factor Umbilical Cord Blood Levels. Fetal Diagn Ther. 2018;43(1):26-33. doi: 10.1159\/000475547.","DOI":"10.1159\/000475547"},{"key":"ref15","doi-asserted-by":"crossref","unstructured":"15. Luttun A, Tjwa M, Carmeliet P. Placental growth factor (PlGF) and its receptor Flt-1 (VEGFR-1): novel therapeutic targets for angiogenic disorders. Ann N Y Acad Sci. 2002;979:80-93. doi:10.1111\/j.1749-6632.2002.tb04870.x","DOI":"10.1111\/j.1749-6632.2002.tb04870.x"},{"key":"ref16","doi-asserted-by":"crossref","unstructured":"16. Sherrell H, Dunn L, Clifton V, Kumar S. Systematic review of maternal Placental Growth Factor levels in late pregnancy as a predictor of adverse intrapartum and perinatal outcomes. Eur J Obstet Gynecol Reprod Biol. 2018 Jun;225:26-34. doi: 10.1016\/j.ejogrb.2018.03.059.","DOI":"10.1016\/j.ejogrb.2018.03.059"},{"key":"ref17","doi-asserted-by":"crossref","unstructured":"17. Woo-Jin Yi, Tae Sung Kim. Melatonin protects mice against stress-induced inflammation through enhancement of M2 macrophage polarization. Int Immunopharmacol. 2017;48: 146-158. doi: 10.1016\/j.intimp.2017.05.006.","DOI":"10.1016\/j.intimp.2017.05.006"},{"key":"ref18","doi-asserted-by":"crossref","unstructured":"18. Mayo JC, Sainz RM, Tan DX, Hardeland R, Leon J, Rodriguez C, Reiter RJ. Antiinflammatory actions of melatonin and its metabolites, N1-acetyl-N2-formyl-5-methoxykynuramine (AFMK) and N1-acetyl-5-methoxykynuramine (AMK), in macro-phages. J Neuroimmunol. 2005;165: 139-49. doi: 10.1016\/j.jneuroim. 2005.05.002.","DOI":"10.1016\/j.jneuroim.2005.05.002"},{"key":"ref19","doi-asserted-by":"crossref","unstructured":"19. Najafi M, Shirazi A, Motevaseli E. Melatonin as an anti-inflammatory agent in radiotherapy. Inflammopharmacol. 2017;25(4):403-413. doi: 10.1007\/s10787-017-0332-5.","DOI":"10.1007\/s10787-017-0332-5"},{"key":"ref20","doi-asserted-by":"crossref","unstructured":"20. Esroy OF, \u00d6zkan N, \u00d6zsoy Z. Effects of melatonin on cytokine release and healing of colonic anastomoses in an experimental sepsis model. Ulus Travma Acil Cerrahi Derg. 2016;22(4): 315-321. doi: 10.5505\/tjtes.2015.49465.","DOI":"10.5505\/tjtes.2015.49465"}],"container-title":["Journal of Medicine and Life"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/medandlife.org\/wp-content\/uploads\/JMedLife-13-548.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,18]],"date-time":"2022-11-18T08:33:48Z","timestamp":1668760428000},"score":1,"resource":{"primary":{"URL":"https:\/\/medandlife.org\/wp-content\/uploads\/JMedLife-13-548.pdf"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":20,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["JMedLife-13-548"],"URL":"https:\/\/doi.org\/10.25122\/jml-2020-0128","relation":{},"ISSN":["1844-122X","1844-3117"],"issn-type":[{"value":"1844-122X","type":"print"},{"value":"1844-3117","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10]]}}}